Analytics for clinical development strategy: Tools and opportunities
In the final part of the series, CRA’s Dr. Nick Davies presents an overview of current and emerging analytical tools and explores the opportunities for their...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Nicholas Davies is a vice president in the Life Sciences Practice of CRA, based in Boston.
Prior to joining CRA, Nicholas Davies was Partner and Global R&D Strategy Leader at a global consulting firm in the Life Sciences industry.
Dr. Davies started his career in the pharmaceutical industry and was an Executive Director of the Strategic Management Group at a multinational pharmaceutical and biotechnology corporation as head of clinical strategy for six years.
Dr. Davies has more than 27 years of experience working in and with pharmaceutical companies as a scientist, strategist, entrepreneur, and leader. His biopharma strategy, consulting, private equity, and industry experience includes: research & clinical development strategy and the science behind it; compliance and quality; business development; and external payer, access, and regulator environments.